PF-05231023, another FGF21 long-acting analog, considerably reduced body weight, plasma TGs and LDLs and increased HDLs and adiponectin in overweight or obese subjects with T2DM (13, 34). The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.